Dongsung Pharm (002210) — Cash Flow Reinvestment Rate
Dongsung Pharm (002210) has a Cash Flow Reinvestment Rate of 0.25x as of June 2025, reinvesting ₩1.07 Billion (capex ₩0.00 plus investments ₩-1.07 Billion) from operating cash flow of ₩4.20 Billion. See cash generation quality of Dongsung Pharm to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dongsung Pharm Cash Flow Reinvestment Rate (2010–2020)
Historical reinvestment intensity for Dongsung Pharm across 4 annual periods. For the full cash flow conversion analysis, see 002210 cash flow conversion.
Annual Cash Flow Reinvestment Rate for Dongsung Pharm (2010–2020)
Year-by-year capital reinvestment analysis for Dongsung Pharm. See Dongsung Pharm leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.51x | ₩12.56 Billion | ₩5.01 Billion | ₩6.92 Billion | ▼ -83.5% |
| 2018 | 15.21x | ₩21.19 Billion | ₩1.39 Billion | ₩2.13 Billion | ▲ +668.2% |
| 2017 | 1.98x | ₩3.56 Billion | ₩1.80 Billion | ₩3.00 Billion | ▲ +588.0% |
| 2010 | 0.29x | ₩1.06 Billion | ₩3.68 Billion | ₩847.33 Million | — |